Category Fascism

Oct 21 2021

White House Announces They are Eager, Prepared and Staged to Start Vaccinating Children 5 to 11 As Soon as Political Health Agencies Give Permission


Posted originally on the conservative tree house on October 20, 2021 | Sundance | 617 Comments

All your children are belong to us.  And so the United States government announces they are now prepared to trigger the “rapid” mass vaccine campaign for children aged 5 to 11.   The cleaving of American citizens will continue unabated with the current administration helping to divide our nation based on vaccination status.  It is a feature, not a flaw…. fundamental change requires it.

The White House says [Fact Sheet Here] they have secured the shots from Pfizer (after giving enough lead-time for politicians to purchase stock in their portfolios), staged the supplies, organized the logistics to ensure no supply chain issues, reinforced the ramparts and delivered prescripted talking to points to media narrative engineers for deployment against unwilling parents.

The Biden administration announced they have prepared the U.S. healthcare system to aggressively, with as much force and speed as possible, drive the childhood vaccination program.  Leveraging existing partnerships and financial dependencies on government spending, the White House expressed confidence.  They do not anticipate any compliance issues with a forceful national rollout:

WHITE HOUSE – “The Administration has procured enough vaccine to support vaccination for the country’s 28 million children ages 5-11 years old. If authorized by the FDA and recommended by the CDC, the Pfizer-BioNTech vaccine for 5-11 year olds will be a dose and formula specifically for this age group. The vaccine will have packaging available in smaller configurations that will make it easier for physicians’ offices and other smaller, community-based providers to offer the vaccine to kids and their families.

Pending FDA authorization, the packaging configuration will be 10-dose vials in cartons of 10 vials each (100 doses total), delivered in a newly updated product shipper, and the vaccine can be stored for up to 10 weeks at standard refrigeration temperatures and 6 months at ultracold temperatures. And, the vaccine will come with all the ancillary supplies that providers need to serve kids, including smaller needles. The U.S. Department of Health and Human Services (HHS) is working hand-in-hand with states to make this vaccine supply available in communities across the country as rapidly as possible.” (read more)

AP notes: “We’re completing the operational planning to ensure vaccinations for kids ages 5 to 11 are available, easy and convenient,” White House COVID-19 coordinator Jeff Zients said, “We’re going to be ready, pending the FDA and CDC decision.” {link} As for youngsters under 5, Pfizer and Moderna are studying their vaccines in children down to 6 months old, with results expected later in the year.

The progression of the child vaccination program is very foreseeable and predictable.  The rollout will be optional for parents; however, once the optional phase has concluded, likely spring 2022, the political healthcare system will unite with the political education system.

Initially Blue states will mandate vaccination of children to attend school or pre-school.  Then the federal government will step in to apply leverage via threats of education funds being withheld for any non-compliant state.  The 2022 mid-term campaign issue over “universal pre-k” funding will support the federal pressure, and eventually anyone receiving federal subsidies under programs structured to support women, infants and children, will be required to participate.

Young children and adolescents will then be given vaccination passports that will permit them to join with the community of safe kids in parks and venues that target families and younger audiences.

Hey, our vaccination app now shows us the nearest location for our next booster along with healthy tips about eating sustainable algae cakes, bugs ‘n stuff.  How cool is that?

.

Oct 20 2021

Southwest Airlines Backs Down And Yellen Forced to Back Down


Armstrong Economics Blog/The Hunt for Taxes Re-Posted Oct 20, 2021 by Martin Armstrong

I have direct contact with many pilots at Southwest and they were reporting that weather had nothing to do with the 1,000 flights that were canceled. Now, the airline was forced to back down and unvaccinated employees can remain. Pilots have been concerned that those who were vaccinated developed blood clots and could no longer work. I have personal friends who were vaccinated and developed blood clots without flying.

Meanwhile, Janet Yellen has been lying to the American people about the lowering of bank reporting to $600. She testified saying: “We have a tax gap that over the next decade is estimated at $7 trillion, namely a shortfall in the amount that IRS is collecting due to a failure of individuals to report the income that they have earned.” Even if the Democrats confiscated all the wealth of the top 100 richest people, they would not collect $7 trillion. This is a deliberate lie and the real objective was to (1) declare cryptocurrencies banks, and then (2) report $600 or greater transaction.

While Babylon Bee made a funny satire out the Yellen’s $600 proposal, this is really no joke. It is technically not illegal to send cash through the mail as long as the (1) source was legal, and (2) the purpose is legal. Of course, there is civil asset forfeiture, which means the government can confiscate whatever it wants and it is your burden to prove it was legal. When I tried to send an ancient Roman coin through the mail and marked it as a coin, they refused to allow it and claimed it was money. No explanation that Rome fell in 476 AD mattered. I had to repackage it and call it a simple antiquity.Now, Janet Yellen has somewhat changed course, supporting a rise in the reporting threshold from $600 to $10,000. Their clever trick to go after the cryptocurrency market and the ridiculous claim that there is $7 trillion in uncollected taxes over the next decade has made the Biden Administration look like not just liars, but fools. Yellen is an absolute disgrace showing a total lack of integrity that she is supposed to be there for the people – not Biden’s agenda which is really that of Klaus Schwab.

Oct 20 2021

Are the US Supply Chain Disruptions Deliberate?


Armstrong Economics Blog/Inflation Re-Posted Oct 20, 2021 by Martin Armstrong

(Image by © Reuters / Alan Devall)

Deputy Treasury Secretary Wally Adeyemo may have accidentally leaked the cause of America’s supply chain issues. “The reality is the only way we’re going to get to a place where we work through this transition is if everyone in America and everyone around the world gets vaccinated,” Adeyemo admitted in an interview with ABC News. Starve them out, let the dissenters suffer, and those who bought into this agenda will turn against them. Adeyemo said that the Biden Administration has already provided “the resources the American people need to make it to the other side.” Basically, everyone should give into the vaccine mandate or face the consequences. They are masking authoritarianism as utilitarianism. The vaccine has not been mandated at the federal level in the US, yet, but it is apparent that the government plans to make life as difficult as possible for those who do not obey.

Echoing the Fed, Adeyemo said that inflation is “transitory,” and “as part of the transition we are seeing higher pieces for some of the things people have to buy… That’s exactly why the president was focused in the American Rescue Plan in ensuring on getting stimulus into the hands of the American people, so they’d be able to buy the products they need.” Yes, the government expects us, the Great Unwashed, to be thankful for their measly handouts to purchase unavailable products at an all-time high. There is a reason people have recently nicknamed the president “bare shelves Biden,” with the hashtags #BareShelvesBiden and #EmptyShelvesJoe becoming a viral sensation.

Although the Biden Administration met with the Ports of Long Beach and Los Angeles, which handles 40% of the nation’s goods, the promise of a 24/7 operation has not yet occurred. There is no ETA for when the ports will begin 24/7 operations either. Some ships are allegedly waiting 12 days at anchor before reaching the dock, and over 60 vessels are idled in the San Pedro Bay at the moment. With one of the nation’s busiest shopping holidays approaching (Black Friday) followed by ongoing seasonal shopping, this matter is likely to turn ugly.

(Click on the image above for higher resolution.)

Taking it a step further, the Democrats are also demanding that the GOP pass the multi-trillion dollar infrastructure bill and are now using it as leverage. Transportation Secretary Pete Buttigieg stated, “One thing that has not been talked about enough is (Moody’s) finding about how the overall ‘Build Back Better’ vision is designed to reduce inflationary pressures. So if you care about inflation, you ought to care about not just the supply chain issues, not just the infrastructure things I work on, but also the provisions in ‘Build Back Better’ like paid family leave, like making it easier to afford childcare, like community college, that are going to give us a stronger labor force and help us deal with that major constraint on economic growth.” Buttigieg also claimed that he knew with certainty that the supply chain crisis is expected to last well into 2022. Perhaps the issue will last into Socrates’ projected political Panic Cycle for 2023.

Oct 20 2021

The Corruption Continues to Surface


Armstrong Economics Blog/Tyranny Re-Posted Oct 20, 2021 by Martin Armstrong

Recently, more sources have been confirming that indeed there was an advance notice that a “virus is coming.” I know even a few hedge funds that took positions on. This has been a very well-orchestrated panic, and it has been intended to alter the world economy. Gates, Soros, and Schwab have all contributed their ideas, so this is not the brainchild of just one character. The recent stories of Gates and his inappropriate emails flirting with employees are just another example that the knight in shining armor is more like the dark black knight of the apocalypse.

The significance of these actions is that the CONFIDENCE in Gates is starting to turn. Eventually, someone will start to investigate and come up with what is starting to come to the surface from multiple sources. I reported at the very beginning that I knew there were phone calls being made and that Schwab had sold for himself and for his World Economic Forum ahead of the COVID Crash of 2020. Others are now confirming that some hedge funds also appear to have been tipped off.

As we enter the third year of this very clever manipulation, we should expect more to surface in 2022. Gates did not resign at Microsoft because of emails hitting on girls. That was a deal that either he resigned or the DOJ would break up Microsoft under the Anti-Trust Act. Bill Gates’ character has not changed. Instead of creating a monopoly in HiTech, he has achieved that in healthcare. He is no more a philanthropist than Jeffrey Epstein. I suggest you read the book “US v Microsoft” to catch a look at Gates’ character. There is often a conflict between men and women because men generally look at a woman and say yes or no. A woman often looks at a man as a fixer-up and that he would be OK with just a little changing. You cannot change a person’s character! We can learn from our mistakes, but the core character will NEVER change, and only a fool assumes that people’s inherent character will change. Yes, I also know men who have tried to force the woman to conform to their ideals. We must accept people as they are and that applies to Bill Gates, and what I believe is his fake philanthropist routine.

Gates has no interest in sharing his vaccines. Instead, he lobbies the Biden Administration and the EU, controlled by Schwab, to buy his vaccines at full price, and they “donate” them to poor countries. That is by no means a philanthropist. There are always side-effects with vaccines, but this one has become so political that the truth is being hidden by governments and the media. I do not think that the majority will suddenly die. Knowing Gates’ obsession with reducing population, I would not rule out that some vaccines are different than others and some batches may be more harmful, intended to cause sterility. But the majority will not be impacted so he can always use that for the excuse that it was not his vaccines. This is just speculation based upon a character that is anything but what it is being projected.

Oct 20 2021

Media Strategy to Inflate Joe Biden Poll Numbers is “Lower Your Expectations”


Posted originally on the conservative tree house on October 19, 2021 | Sundance | 149 Comments

As just about everything falls apart due to intended outcomes from Biden policy, it is increasingly obvious the water carriers for the regime are struggling to find new ways to defend the White House.  However, a recent approach seems to have gained traction and was noted by Tucker Carlson tonight.

Instead of the media and White House defending the high gas prices, massive food price increases, fuel costs, home heating costs, energy costs, and empty shelves as a result of regulatory strangleholds and poor policy, the narrative engineers are now telling everyone to “lower their expectations” for what things should be.   That way if you walk into a supermarket and there is an apple for sale, you will be surprised at the apple and avoid noticing hundreds of feet of empty shelves.

In his opening monologue Tucker Carlson gives several examples.  WATCH:https://www.youtube.com/embed/JowIQEYfqEE?feature=oembed

“This is fine”…

Oct 20 2021

9 In 10 Large Employers Concerned They Will Lose Employees Over Vaccine Mandate


Posted originally on the conservative tree house October 19, 2021 | Sundance | 243 Comments

In an unusual twist to the strength of the multinationals, many large corporations are worried they will lose critical employees to smaller organizations with less than 100 employees who do not have to enforce the national worker vaccine mandate.

By itself the 100 worker rule, in combination with the exemptions being provided by the federal government for some politically connected union organizations, would seem to undercut the premise of the “national health emergency.”  If the COVID pandemic is such a national threat, why would any groups be excluded from the mandate?  However, until the Dept of Labor rule is officially registered, court cases to hear such arguments are not possible.

A recent survey by The Society for Human Resource Management, as shared by The Hill, indicates that 9 out of 10 large employers are concerned about losing significant amounts of workers due to the federal mandate:

The Hill – […] The survey reveals uneasiness among employers over the impending workplace rule, which will require employers with 100 or more employees to mandate COVID-19 vaccinations or frequent testing. They’re most concerned about losing workers amid an extremely tight labor market. 

Another two-thirds of employers surveyed said that they cannot afford to pay for weekly COVID-19 testing for unvaccinated workers.   […] Others are worried that they could lose unvaccinated workers to rival firms with fewer than 100 employees or to independent contracting companies that aren’t subject to the rule. (read more)

It will be interesting to see if, and how quickly, a parallel economy with a vaccination option workforce, will take root.

Oct 20 2021

San Francisco Shuts Down In-N-Out Burger For Refusing to Be Vaccine Police – Company Says “We refuse to become the vaccination police for any government”


Posted originally on the conservative tree house on October 19, 2021 | Sundance | 196 Comments

The City of San Francisco and Mayor London Breed announced a vaccination mandate in August for any business offering indoor dining.  According to the order, all businesses are required to ask for proof of vaccination from customers.  San Francisco was the second city in the country, behind New York, in making such a regional mandate.

The owners and operators of In-N-Out burger, refused to be vaccination police and discriminate against their customers.  The City of San Francisco shut them down.  The restaurant still offers outside seating and take out, but they will not participate in vaccine checkpoints.

CALIFORNIA – “In an email to Eater SF the San Francisco Department of Public Health says it’s been trying to get In-N-Out to adhere to the city’s vaccination order for weeks. The city’s Joint Information Center Outreach Team first visited the restaurant on September 24 after receiving a complaint to the 311 non-emergency service line.

Inspectors from the Environmental Health division who followed up on October 6, found the restaurant was still in violation of the health order and issued a Notice to Comply. The department finally issued a Notice of Closure on October 14, at which point the restaurant was “instructed to cease all operations on site immediately because of the threat it poses to public health,” according to the Department of Public Health. The owner of the property, Anchorage Holdings LP, which is based in Addison, Texas, was also issued a Notice of Violation.

The company says it has “properly and clearly posted signage to communicate local vaccination requirements.” But In-N-Out also admits employees were not checking customers’ vaccinations cards and IDs, nor were they preventing customers who are not able to prove they’ve been vaccinated from entering the restaurant, which the health department told the company that staff must do.

“As a Company, In-N-Out Burger strongly believes in the highest form of customer service and to us that means serving all Customers who visit us and making all Customers feel welcome,” the statement continues. “We refuse to become the vaccination police for any government. It is unreasonable, invasive, and unsafe to force our restaurant Associates to segregate Customers into those who may be served and those who may not, whether based on the documentation they carry, or any other reason.” (read more)

Oct 20 2021

FBI Raids DC Home of Oleg Deripaska, Chris Steele’s Former Employer and Central Player in Corrupt FBI Operation Against Donald Trump


Posted originally on the conservative tree house on October 19, 2021 | Sundance | 387 Comments

First things first.  I feel the need to apologize to Mr. Deripaska.  It is an unfortunate situation to see Oleg Deripaska receiving the Julian Assange treatment.  Yes, that is exactly what is happening today as the institutionally corrupt FBI and DOJ attempt to throw a bag over Deripaska, in order to cover up their previous operations.

That said, Oleg Deripaska is not stupid, he knows these players and knows exactly what game the corrupt U.S. officials are playing.   It was transparently obvious over the past few days that something was happening in the background.  The Fourth Branch of Government, intelligence apparatus, Dept of Justice, FBI, and media enablers -writ large- began conducting an information warfare operation.

It is not coincidental: (1) the collective media apparatus brought Chris Steele out of hiding for an ABC interview with George Stephanopoulos, and a rehabilitation of his Dossier effort; then (2) the intelligence apparatus began scrubbing the Dossier from public downloads; then (3) the FBI apparatus notifies the media in advance and shows up to raid the home of a central participant in the Dossier story line.  There are no coincidences of this connective scale.

This is a full-blown propaganda operation carried out by the DC-based Fourth Branch of Government.   These moves indicate a likelihood that John Durham is almost finished with the spray paint operation.   Remember, Lisa Monaco is Deputy AG, and John Carlin is back in the DOJ-NSD position. Both of them participated in the illegal weaponization and political surveillance operations against candidate Trump (that involved Deripaska), and both are now central to the ongoing clean-up and cover-up operation.

DC is a horrible and abusive vehicle; rusted to the core with metastatic corruption.  Bill Barr was the bondo application and John Durham is the spray paint.  The clear objective is to cover-up the corruption from public view and giving Oleg Deripaska the Julian Assange treatment is one part of that process.  The FBI is to Washington DC what the FSB represents to Moscow.

Today, FBI agents from DC’s main office as well as Washington Field Office (WFO) raided the home of Russian Billionaire Oleg Deripaska.   This move comes just 36 hours after CTH outlined the risk that Deripaska represents to all of the corrupt DC officials who participated in the Trump-Russia attack scheme. {Go Deep}

VIA NBC – FBI agents on Tuesday swarmed the home of Russian oligarch Oleg Deripaska in Washington, D.C., an agency spokesperson confirmed to NBC News.

The reason for their presence wasn’t immediately clear. The spokesperson said the agency is conducting “law enforcement activity at the home,” but wouldn’t elaborate.

The investigation is being led by federal investigators in New York City, according to two officials briefed on the matter.  (read more)

The FBI told news outlets what they were doing in advance so the cameras could be present as part of the operation (similar to the Roger Stone raid).  Unfortunately, most news consumers cannot see the script and performance that underpins the corrupt motive.  [NBC News Segment Here] and below is a lengthy video of the entire raid:

Christopher Steele was actually a contracted employee of Deripaska, at least Deripaska was paying Chris Steele for some type of work in the U.K.  Oleg Deripaska is a typically sketchy wealthy Russian with some quirky aspects to his humor.  Oleg’s U.S. lawyer was a guy named Adam Waldman.  You might remember that Adam Waldman was also the legal liaison between Chris Steele and SSCI Vice-Chairman Mark Warner {Go Deep}.

Adam Waldman is the connective tissue between Chris Steele, Oleg Deripaska and another name from the SSCI, former staffer Dan Jones.  When Senator Chuck Grassley wanted to question the lawyer/lobbyist Adam Waldman, Waldman lied to avoid testimony {Go Deep}.  Unfortunately it was a line of Senate query that was quickly dropped.

Oleg Deripaska was on his yacht in the summer of 2016 with a sketchy Russian sex/intelligence worker named Anastasia Vashukevich (27).  [Both Pictured Left]

Vashukevich is the Belarusian woman who was being held in a prison in Thailand under charges of recruiting women to act as prostitutes and escorts.  {Go Deep}

Ms. Vashukevich name surfaced early in 2018 when CNN claimed she had dirt on Trump and “tapes” of some sort relating to Deripaska and his activities with contacts around the 2016 election.  [More Backstory]

In the height of the Trump-Russia madness, CNN sent Ivan Watson to Thailand to interview Ms. Vashukevich in the hopes that she could validate the “hookers” and “pee-tapes” material that was in the Steele Dossier.  However, by the time CNN arrived, Anastasia changed her mind.

It turned out the recording Ms. Vashukevich was promoting/leveraging, was actually a recording of Oleg Deripaska; and, at his request she returned them to him.

FOX NEWS: […]  Vashukevich told The Associated Press that she had turned over audio recordings to Russian oligarch Oleg Deripaska, whose conversations about election interference she claimed to have taped.

She has said she provided “escort” services to Deripaska, who is close to Russian President Vladimir Putin and who has links to Paul Manafort, Trump’s former campaign manager now being tried in the United States on money laundering and other charges.

Speaking to an AP reporter in the courtroom in Pattaya, Vashukevich said she had promised Deripaska she would no longer speak on the matter, and that he had already promised her something in return for not making that evidence public. (read more)

The tapes Ms. Vashukevich was discussing at the time (trying to leverage her way out of jail) was a previous recording by Deripaska of a conversation between Oleg and his retained employee Christopher Steele about then presidential candidate Donald Trump.   This is the conversation where Trump, Russian hookers and pee-tapes came up.  Keep in mind, Oleg likely knew what Steele’s questions were for; Oleg knew what Chris Steele did for a living, and Oleg had a motive to snark at the entire operation and U.S. election.

Deripaska didn’t trust anyone related to intelligence operations in either the U.K or the U.S, and Deripaska had previously been burned by the FBI in 2009 after they asked for his help. {Go Deep}

In 2009 the FBI, then headed by Robert Mueller, requested the assistance of Russian billionaire Oleg Deripaska in an operation to retrieve former FBI officer and CIA resource Robert Levinson who was captured in Iran two years earlier. The agent assigned to engage Deripaska was Andrew McCabe; the primary FBI need was financing and operational support. Deripaska spent around $25 million and would have succeeded except the U.S. State Department, then headed by Hillary Clinton, backed out.

In the summer of 2016, Steele was under retainer by Deripaska and also working for Fusion-GPS.  In hindsight, the conversation was almost certainly part of the research Steele was doing for his Fusion-GPS assignment and assembly of the dossier into Trump.  Oleg was an easy and obvious source, and Anastasia Vashukevich just happened to be with Oleg when the conversation took place.  She snagged the tapes upon departure, she was busted in Thailand and tried to use the info to get out.

Keep in mind, in September of 2016 Andrew McCabe was Deputy Director of the FBI, when two FBI agents approached Deripaska in New York – asking for his help. The FBI request was for Deripaska to outline Trump’s former campaign manager Paul Manafort as a tool of the Kremlin. Deripaska once hired Manafort as a political adviser and invested money with him in a business venture that went bad. Deripaska sued Manafort, alleging he stole money. However, according to a John Solomon article, despite Deripaska’s disposition toward Manafort, he viewed the FBI request as absurd. He laughed the FBI away, telling them: “You are trying to create something out of nothing.”

After Trump won the 2016 election, the entire apparatus of the U.S. intelligence system and DOJ turned on Deripaska because he now represented a risk {Go Deep}.

Now, watch this video of Tom Cotton asking FBI Director Chris Wray about Deripaska:

Byron York previously outlined new documents showing the communication between Trump Dossier author Christopher Steele and DOJ official Bruce Ohr.
Within the early 2016 discussions, Chris Steele appeared to be advocating to Bruce Ohr on behalf of Oleg Deripaska who was banned from travel into the U.S. by the State Department.

(Byron York) Emails in 2016 between former British spy Christopher Steele and Justice Department official Bruce Ohr suggest Steele was deeply concerned about the legal status of a Putin-linked Russian oligarch, and at times seemed to be advocating on the oligarch’s behalf, in the same time period Steele worked on collecting the Russia-related allegations against Donald Trump that came to be known as the Trump dossier. The emails show Steele and Ohr were in frequent contact, that they intermingled talk about Steele’s research and the oligarch’s affairs, and that Glenn Simpson, head of the dirt-digging group Fusion GPS that hired Steele to compile the dossier, was also part of the ongoing conversation. (more)

I strongly urge you to read the York article, because I’m going to expand on the Deripaska angle from the context of the reader understanding the relationship.

It is likely that Oleg’s 2016 entry into the U.S. was facilitated as part of a quid-pro-quo; either agreed in advance, or, more likely, planned by the DOJ/FBI for later use in their 2016 Trump operation; as evidenced in the September 2016 FBI request. Regardless of the planning aspect, billionaire Deripaska is connected to Chris Steele, a source for Chris Steele, and likely even the employer of Chris Steele.

The FBI used Oleg Deripaska (source), and Oleg Deripaska used the FBI (visa).

Here’s where it gets interesting….

In a May 2018 article, John Solomon reported that Deripaska wanted to testify to congress in 2017 without any immunity request, but was rebuked. Who blocked his testimony?

In 2017, Oleg Deripaska was represented in the U.S. by Adam Waldman. Mr. Waldman was also representing Christopher Steele, the author of the Dossier. Waldman was the liaison Senator Mark Warner (Senate Intelligence Committee Vice-Chairman) was using to try and set up a secret meeting with Christopher Steele. {Text Messages}


As you can see from the text messages (more here), the House Intelligence Committee wanted to interview Deripaska. However, based on their ongoing contact and relationship Deripaska’s lawyer, Adam Waldman, asks Senate Intelligence Committee Vice-Chair Mark Warner for feedback.

Oleg Deripaska was blocked from testifying to congress. Now, it was obviously not from the HPSCI (Nunes Committee), but rather by the Senate Intel Committee, via then Vice-Chair Senator Mark Warner. Oh yes, THAT Senator Mark Warner again.

Now, think about this…. Yes, with Oleg Deripaska in the picture there was indeed Russian meddling in the 2016 election; only, it wasn’t the type of meddling currently being sold. The FBI/DOJ were using Russian Deripaska to frame their Russian conspiracy narrative. It is almost a certainty that Deripaska was one of Chris Steele’s sources for the dossier.

Now, put yourself in Deripaska’s shoes and think about what happens AFTER candidate Donald Trump surprisingly wins the election.

All of a sudden Deripaska the asset becomes a risk to the corrupt Scheme Team (DOJ/FBI et al); especially as the DOJ/FBI then execute the “insurance policy” effort against Donald Trump…. and eventually enlist Robert Mueller.

It is entirely possible for a Russian to be blackmailing someone, but it ain’t Trump vulnerable to blackmail; it’s the conspiracy crew within the DOJ and FBI. Deripaska now has blackmail material on Comey, McCabe and crew.

After the 2017 (first year) failure of the “insurance policy”, it now seems more likely President Trump will outlive the soft coup. In May 2018, Oleg tells Waldman to call John Solomon and tell him the story from a perspective favorable to Deripaska.

As the story is told, in 2017 Oleg was more than willing to testify to congress… likely laughing the entire time… but the corrupt participants within congress damned sure couldn’t let Deripaska testify. Enter corrupt SSCI Vice-Chairman Mark Warner:

Um, we’ve got a problem here Mark…

The Russians (Deripaska) really did have leverage and blackmail… but it wasn’t over Donald Trump.  Factually, Oleg had blackmail on Comey, McCabe and the DOJ/FBI conspiracy crew. Oleg Deripaska must be kept away from congress and away from exposing the scheme.

Guess who else must be controlled and/or kept away from congress?  Yup, Julian Assange.  Wikileaks founder Julian Assange has evidence the Russians didn’t hack the DNC.

Between Deripaska’s first-hand knowledge of the DOJ/FBI work on both the Dossier and the DOJ/FBI intention for his use as a witness; and Julian Assange’s first-hand knowledge of who actually took the DNC email communication;… well, the entire Russian narrative could explode in their faces.

Control is needed.  Control is a reaction to fear.

You can almost hear the corrupt U.S. Intelligence officials calling their U.K. GCHQ partners in Britain and yelling at them to do something, anything, and for the love of God, shut down Assange’s access to the internet STAT.   Yeah, funny that.

Now, who moves into position to control Julian Assange?

Well, well, well…. Lookie here? Who dat? Apparently the SSCI wants to interview WikiLeaks founder Julian Assange, in a closed session. Signed by none other than our corrupt-o-crats, former SSCI Chairman Richard Burr and Vice-Chair Mark Warner. Yeah, funny that.

Lest anyone need a reminder…. “The most corrupt part of Congress is the Senate Select Committee on Intelligence (SSCI). The SSCI is the center of the deepest part of the Deep State swamp. The SSCI never, ever, E.V.E.R… does anything that does not protect and advance the self-interest of the corrupt Washington DC professional political class.”  The SSCI enaables the Fourth Branch of Government.


Now do we see why the SSCI is the center of protecting the entire fraudulent apparatus?

It’s somewhat humorous to look at this Spygate fiasco from the perspective of Oleg Deripaska. He likely had lots of laughs with his Ruskie friends about these stoopid Amerikans, and how the intelligence apparatus of the United States of America is controlled by corrupt politicians trying to save themselves and the corrupt institutions.

The Russians, notorious for sowing discord, are being used as a shield from sunlight upon actions taken by U.S. own intelligence officers: James Comey, Andrew McCabe, Loretta Lynch, Sally Yates, John Brennan, James Clapper etc.

Think about it from the perspective of the DOJ/FBI conspiracy group reading how Oleg instructed Adam Waldman to present his story.

With Deripaska telling John Solomon (via Adam Waldman) how the FBI contacted him; the background of their prior collaborative relationship; and the likelihood of Deripaska giving information to Chris Steele for the dossier; the scheme team really, really, needed to double down on the Russian conspiracy narrative in case Oleg ever did testify to congress.

By doubling down on the Russian Collusion narrative, the conspirators created a ‘catch-22’ defense. They could/can claim Deripaska was/is giving disinformation in his version of events to support the interests of Russia and sewing chaos in America etc. And any Republican who would give Deripaska a platform to tell what happened in 2016 would be doing the bidding of Vladimir Putin. See how that works?

Throughout the Trump term in office, the DOJ, FBI and intelligence community protected themselves by impugning the motives of Oleg Deripaska, and diminishing his credibility under the auspices of Russian disinformation.  However, with Trump out of office, the intent of those same DOJ and FBI officials shifts from impugning motives to putting a bag over Deripaska and keeping him locked down.

On the day after Mueller completed his investigation in April 2019, the FBI moved to arrest Julian Assange.

On the day after Chris Steele and ABC broadcast their Steele Dossier documentary, the FBI moves to raid Oleg Deripaska.

See how that works?

Oct 20 2021

OSHA Demands Not To Know Things


Posted originally on the conservative tree house on October 19, 2021 | Sundance | 300 Comments

Axiom: ‘In order to advance a communist ideological belief system, the rulers must *pretend* not to know things’.

Individually, in groups, or in the systems they construct, that axiom has always been true.

The Dept of Labor and OSHA standard on adverse Vaccine events:

(LINK)

“OSHA will not enforce 29 CFR 1904’s recording requirements to require any employers to record worker side effects from COVID-19 vaccination.”

The Biden administration is forcing you to take the jab in order to work, and simultaneously the Biden administration doesn’t want the employer to tell them about workers who are injured by the jab.   Simply more evidence the vaccine mandate is not about your health.

Oct 19 2021

Is there evidence that natural exposure immunity to COVID virus is similar or superior to vaccine-induced immunity, and should we force/mandate these vaccines on our healthy military and police?


Posted originally on trialsitenews.com by PaulAlexanderOctober 15, 202110 Comments

Is there evidence that natural exposure immunity to COVID virus is similar or superior to vaccine induced immunity and should we force/mandate these vaccines on our healthy military and police?

Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite. FREE to read and SHARE without paying.

Authored by Paul Elias Alexander, PhD, Dr. Ramin Oskoui, MD, and Dr. Peter McCullough, MD

I argue for the superiority of natural immunity over the narrow ‘spike-specific’ immature immunity conferred by the COVID injections.  Yet you can assess the available body of evidence yourself and make a judgment. The refusal by NIAID’s Anthony Fauci, CDC’s Rochelle Walensky, and NIH’s Francis Collins to recognize natural immunity as similar to or even superior to vaccine immunity is outrageous, unscientific, and downright absurd. We said before that our children must be considered already immune and vaccinated (based on biological and molecular evidence) and leave them alone with these sub-optimal, non-sterilizing, unneeded injections, and now we say the very same for our militaries and police. Leave them to hell alone with vaccine mandates for they can make personal informed decisions while at the same time being at vanishingly low risk for severe outcome from COVID! We can potentially cause needless harm and death to our military and police with these safety untested injections. Allow our best people (in fact everyone) to balance the benefits and harms (risks) especially if they are already COVID recovered and have gained rich, robust, sterilizing, life-long natural immunity. One and done!  Allow proper informed consent (for the first time). Follow the Nuremberg Code of Ethics etc. Below is the existing body of evidence on natural immunity versus vaccine immunity as it relates to COVID-19 (Table 1). This represents the most updated and comprehensive library list of over 70 of the highest-quality, complete, most robust scientific studies and evidence reports/position statements on natural immunity as compared to the COVID-19 vaccine-induced immunity and allow you to draw your own conclusion:  

Table 1: Evidence on natural immunity versus COVID-19 vaccine-induced immunity as of October 15th, 2021

Study/report title, author, and year published and interactive url linkPredominant finding on natural immunity
1) Necessity of COVID-19 vaccination in previously infected individuals, Shrestha, 2021“Cumulative incidence of COVID-19 was examined among 52,238 employees in an American healthcare system. The cumulative incidence of SARS-CoV-2 infection remained almost zero among previously infected unvaccinated subjects, previously infected subjects who were vaccinated, and previously uninfected subjects who were vaccinated, compared with a steady increase in cumulative incidence among previously uninfected subjects who remained unvaccinated. Not one of the 1359 previously infected subjects who remained unvaccinated had a SARS-CoV-2 infection over the duration of the study. Individuals who have had SARS-CoV-2 infection are unlikely to benefit from COVID-19 vaccination…”
2) SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls, Le Bert, 2020“Studied T cell responses against the structural (nucleocapsid (N) protein) and non-structural (NSP7 and NSP13 of ORF1) regions of SARS-CoV-2 in individuals convalescing from coronavirus disease 2019 (COVID-19) (n = 36). In all of these individuals, we found CD4 and CD8 T cells that recognized multiple regions of the N protein…showed that patients (n = 23) who recovered from SARS possess long-lasting memory T cells that are reactive to the N protein of SARS-CoV 17 years after the outbreak of SARS in 2003; these T cells displayed robust cross-reactivity to the N protein of SARS-CoV-2.”
3) Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections,Gazit, 2021“A retrospective observational study comparing three groups: (1) SARS-CoV-2-naïve individuals who received a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2 vaccine, (2) previously infected individuals who have not been vaccinated, and (3) previously infected and single dose vaccinated individuals found para a 13 fold increased risk of breakthrough Delta infections in double vaccinated persons, and a 27 fold increased risk for symptomatic breakthrough infection in the double vaccinated relative to the natural immunity recovered persons…the risk of hospitalization was 8 times higher in the double vaccinated (para)…this analysis demonstrated that natural immunity affords longer lasting and stronger protection against infection, symptomatic disease and hospitalization due to the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity.”
4) Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection, Le Bert, 2021“Studied SARS-CoV-2–specific T cells in a cohort of asymptomatic (n = 85) and symptomatic (n = 75) COVID-19 patients after seroconversion…thus, asymptomatic SARS-CoV-2–infected individuals are not characterized by weak antiviral immunity; on the contrary, they mount a highly functional virus-specific cellular immune response.”
5) Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection, Israel, 2021“A total of 2,653 individuals fully vaccinated by two doses of vaccine during the study period and 4,361 convalescent patients were included. Higher SARS-CoV-2 IgG antibody titers were observed in vaccinated individuals (median 1581 AU/mL IQR [533.8-5644.6]) after the second vaccination, than in convalescent individuals (median 355.3 AU/mL IQR [141.2-998.7]; p<0.001). In vaccinated subjects, antibody titers decreased by up to 40% each subsequent month while in convalescents they decreased by less than 5% per month…this study demonstrates individuals who received the Pfizer-BioNTech mRNA vaccine have different kinetics of antibody levels compared to patients who had been infected with the SARS-CoV-2 virus, with higher initial levels but a much faster exponential decrease in the first group”.
6) SARS-CoV-2 re-infection risk in Austria, Pilz, 2021Researchers recorded “40 tentative re-infections in 14, 840 COVID-19 survivors of the first wave (0.27%) and 253 581 infections in 8, 885, 640 individuals of the remaining general population (2.85%) translating into an odds ratio (95% confidence interval) of 0.09 (0.07 to 0.13)…relatively low re-infection rate of SARS-CoV-2 in Austria. Protection against SARS-CoV-2 after natural infection is comparable with the highest available estimates on vaccine efficacies.” Additionally, hospitalization in only five out of 14,840 (0.03%) people and death in one out of 14,840 (0.01%) (tentative re-infection).
7) mRNA vaccine-induced SARS-CoV-2-specific T cells recognize B.1.1.7 and B.1.351 variants but differ in longevity and homing properties depending on prior infection status, Neidleman, 2021“Spike-specific T cells from convalescent vaccinees differed strikingly from those of infection-naïve vaccinees, with phenotypic features suggesting superior long-term persistence and ability to home to the respiratory tract including the nasopharynx. These results provide reassurance that vaccine-elicited T cells respond robustly to the B.1.1.7 and B.1.351 variants, confirm that convalescents may not need a second vaccine dose.”
8) Good news: Mild COVID-19 induces lasting antibody protection, Bhandari, 2021“Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all the while. The findings, published May 24 in the journal Nature, suggest that mild cases of COVID-19 leave those infected with lasting antibody protection and that repeated bouts of illness are likely to be uncommon.”
9) Robust neutralizing antibodies to SARS-CoV-2 infection persist for months, Wajnberg, 2021“Neutralizing antibody titers against the SARS-CoV-2 spike protein persisted for at least 5 months after infection. Although continued monitoring of this cohort will be needed to confirm the longevity and potency of this response, these preliminary results suggest that the chance of reinfection may be lower than is currently feared.”
10) Evolution of Antibody Immunity to SARS-CoV-2, Gaebler, 2020“Concurrently, neutralizing activity in plasma decreases by five-fold in pseudo-type virus assays. In contrast, the number of RBD-specific memory B cells is unchanged. Memory B cells display clonal turnover after 6.2 months, and the antibodies they express have greater somatic hypermutation, increased potency and resistance to RBD mutations, indicative of continued evolution of the humoral response…we conclude that the memory B cell response to SARS-CoV-2 evolves between 1.3 and 6.2 months after infection in a manner that is consistent with antigen persistence.”
11) Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans, Haveri, 2021“Assessed the persistence of serum antibodies following WT SARS-CoV-2 infection at 8 and 13 months after diagnosis in 367 individuals…found that NAb against the WT virus persisted in 89% and S-IgG in 97% of subjects for at least 13 months after infection.”
12) Quantifying the risk of SARS‐CoV‐2 reinfection over time, Murchu, 2021“Eleven large cohort studies were identified that estimated the risk of SARS‐CoV‐2 reinfection over time, including three that enrolled healthcare workers and two that enrolled residents and staff of elderly care homes. Across studies, the total number of PCR‐positive or antibody‐positive participants at baseline was 615,777, and the maximum duration of follow‐up was more than 10 months in three studies. Reinfection was an uncommon event (absolute rate 0%–1.1%), with no study reporting an increase in the risk of reinfection over time.”
13) Natural immunity to covid is powerful. Policymakers seem afraid to say so, Makary, 2021Makary writes “it’s okay to have an incorrect scientific hypothesis. But when new data proves it wrong, you have to adapt. Unfortunately, many elected leaders and public health officials have held on far too long to the hypothesis that natural immunity offers unreliable protection against covid-19 — a contention that is being rapidly debunked by science. More than 15 studies have demonstrated the power of immunity acquired by previously having the virus. A 700,000-person study from Israel two weeks ago found that those who had experienced prior infections were 27 times less likely to get a second symptomatic covid infection than those who were vaccinated. This affirmed a June Cleveland Clinic study of health-care workers (who are often exposed to the virus), in which none who had previously tested positive for the coronavirus got reinfected. The study authors concluded that “individuals who have had SARS-CoV-2 infection are unlikely to benefit from covid-19 vaccination.” And in May, a Washington University study found that even a mild covid infection resulted in long-lasting immunity.”
14) SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity, Nielsen, 2021“203 recovered SARS-CoV-2 infected patients in Denmark between April 3rd and July 9th 2020, at least 14 days after COVID-19 symptom recovery… report broad serological profiles within the cohort, detecting antibody binding to other human coronaviruses… the viral surface spike protein was identified as the dominant target for both neutralizing antibodies and CD8+ T-cell responses. Overall, the majority of patients had robust adaptive immune responses, regardless of their disease severity.”
15) Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel, Goldberg, 2021“Analyze an updated individual-level database of the entire population of Israel to assess the protection efficacy of both prior infection and vaccination in preventing subsequent SARS-CoV-2 infection, hospitalization with COVID-19, severe disease, and death due to COVID-19… vaccination was highly effective with overall estimated efficacy for documented infection of 92·8% (CI:[92·6, 93·0]); hospitalization 94·2% (CI:[93·6, 94·7]); severe illness 94·4% (CI:[93·6, 95·0]); and death 93·7% (CI:[92·5, 94·7]). Similarly, the overall estimated level of protection from prior SARS-CoV-2 infection for documented infection is 94·8% (CI: [94·4, 95·1]); hospitalization 94·1% (CI: [91·9, 95·7]); and severe illness 96·4% (CI: [92·5, 98·3])…results question the need to vaccinate previously-infected individuals.”
16) Incidence of Severe Acute Respiratory Syndrome Coronavirus-2 infection among previously infected or vaccinated employees, Kojima, 2021“Employees were divided into three groups: (1) SARS-CoV-2 naïve and unvaccinated, (2) previous SARS-CoV-2 infection, and (3) vaccinated. Person-days were measured from the date of the employee first test and truncated at the end of the observation period. SARS-CoV-2 infection was defined as two positive SARS-CoV-2 PCR tests in a 30-day period… 4313, 254 and 739 employee records for groups 1, 2, and 3…previous SARS-CoV-2 infection and vaccination for SARS-CoV-2 were associated with decreased risk for infection or re-infection with SARS-CoV-2 in a routinely screened workforce. The was no difference in the infection incidence between vaccinated individuals and individuals with previous infection.” 
17) Having SARS-CoV-2 once confers much greater immunity than a vaccine—but vaccination remains vital, Wadman, 2021“Israelis who had an infection were more protected against the Delta coronavirus variant than those who had an already highly effective COVID-19 vaccine…the newly released data show people who once had a SARS-CoV-2 infection were much less likely than never-infected, vaccinated people to get Delta, develop symptoms from it, or become hospitalized with serious COVID-19.”
18) One-year sustained cellular and humoral immunities of COVID-19 convalescents, Zhang, 2021“A systematic antigen-specific immune evaluation in 101 COVID-19 convalescents; SARS-CoV-2-specific IgG antibodies, and also NAb can persist among over 95% COVID-19 convalescents from 6 months to 12 months after disease onset. At least 19/71 (26%) of COVID-19 convalescents (double positive in ELISA and MCLIA) had detectable circulating IgM antibody against SARS-CoV-2 at 12m post-disease onset. Notably, the percentages of convalescents with positive SARS-CoV-2-specific T-cell responses (at least one of the SARS-CoV-2 antigen S1, S2, M and N protein) were 71/76 (93%) and 67/73 (92%) at 6m and 12m, respectively.” 
19) Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19, Rodda, 2021“Recovered individuals developed SARS-CoV-2-specific immunoglobulin (IgG) antibodies, neutralizing plasma, and memory B and memory T cells that persisted for at least 3 months. Our data further reveal that SARS-CoV-2-specific IgG memory B cells increased over time. Additionally, SARS-CoV-2-specific memory lymphocytes exhibited characteristics associated with potent antiviral function: memory T cells secreted cytokines and expanded upon antigen re-encounter, whereas memory B cells expressed receptors capable of neutralizing virus when expressed as monoclonal antibodies. Therefore, mild COVID-19 elicits memory lymphocytes that persist and display functional hallmarks of antiviral immunity.”
20) Discrete Immune Response Signature to SARS-CoV-2 mRNA Vaccination Versus Infection, Ivanova, 2021“Performed multimodal single-cell sequencing on peripheral blood of patients with acute COVID-19 and healthy volunteers before and after receiving the SARS-CoV-2 BNT162b2 mRNA vaccine to compare the immune responses elicited by the virus and by this vaccine…both infection and vaccination induced robust innate and adaptive immune responses, our analysis revealed significant qualitative differences between the two types of immune challenges. In COVID-19 patients, immune responses were characterized by a highly augmented interferon response which was largely absent in vaccine recipients. Increased interferon signaling likely contributed to the observed dramatic upregulation of cytotoxic genes in the peripheral T cells and innate-like lymphocytes in patients but not in immunized subjects. Analysis of B and T cell receptor repertoires revealed that while the majority of clonal B and T cells in COVID-19 patients were effector cells, in vaccine recipients clonally expanded cells were primarily circulating memory cells…we observed the presence of cytotoxic CD4 T cells in COVID-19 patients that were largely absent in healthy volunteers following immunization. While hyper-activation of inflammatory responses and cytotoxic cells may contribute to immunopathology in severe illness, in mild and moderate disease, these features are indicative of protective immune responses and resolution of infection.”
21) SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans, Turner, 2021“Bone marrow plasma cells (BMPCs) are a persistent and essential source of protective antibodies… durable serum antibody titres are maintained by long-lived plasma cells—non-replicating, antigen-specific plasma cells that are detected in the bone marrow long after the clearance of the antigen … S-binding BMPCs are quiescent, which suggests that they are part of a stable compartment. Consistently, circulating resting memory B cells directed against SARS-CoV-2 S were detected in the convalescent individuals. Overall, our results indicate that mild infection with SARS-CoV-2 induces robust antigen-specific, long-lived humoral immune memory in humans…overall, our data provide strong evidence that SARS-CoV-2 infection in humans robustly establishes the two arms of humoral immune memory: long-lived bone marrow plasma cells (BMPCs) and memory B-cells.”
22) SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN), Jane Hall, 2021“The SARS-CoV-2 Immunity and Reinfection Evaluation study… 30 625 participants were enrolled into the study… a previous history of SARS-CoV-2 infection was associated with an 84% lower risk of infection, with median protective effect observed 7 months following primary infection. This time period is the minimum probable effect because seroconversions were not included. This study shows that previous infection with SARS-CoV-2 induces effective immunity to future infections in most individuals.”
23) Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers, Houlihan, 2020“Enrolled 200 patient-facing HCWs between March 26 and April 8, 2020…represents a 13% infection rate (i.e. 14 of 112 HCWs) within the 1 month of follow-up in those with no evidence of antibodies or viral shedding at enrolment. By contrast, of 33 HCWs who tested positive by serology but tested negative by RT-PCR at enrolment, 32 remained negative by RT-PCR through follow-up, and one tested positive by RT-PCR on days 8 and 13 after enrolment.”
24) Antibodies to SARS-CoV-2 are associated with protection against reinfection, Lumley, 2021“Critical to understand whether infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) protects from subsequent reinfection… 12219 HCWs participated…prior SARS-CoV-2 infection that generated antibody responses offered protection from reinfection for most people in the six months following infection.”
25) Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells, Cohen, 2021“Evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of >200 days suggesting the generation of longer-lived plasma cells… most recovered COVID-19 patients mount broad, durable immunity after infection, spike IgG+ memory B cells increase and persist post-infection, durable polyfunctional CD4 and CD8 T cells recognize distinct viral epitope regions.”
26) Single cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine, Sureshchandra, 2021“Used single-cell RNA sequencing and functional assays to compare humoral and cellular responses to two doses of mRNA vaccine with responses observed in convalescent individuals with asymptomatic disease… natural infection induced expansion of larger CD8 T cell clones occupied distinct clusters, likely due to the recognition of a broader set of viral epitopes presented by the virus not seen in the mRNA vaccine.”
27) SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy, Abu-Raddad, 2021“SARS-CoV-2 antibody-positive persons from April 16 to December 31, 2020 with a PCR-positive swab ≥14 days after the first-positive antibody test were investigated for evidence of reinfection, 43,044 antibody-positive persons who were followed for a median of 16.3 weeks…reinfection is rare in the young and international population of Qatar. Natural infection appears to elicit strong protection against reinfection with an efficacy ~95% for at least seven months.”
28) Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity, Ripperger, 2020“Conducted a serological study to define correlates of immunity against SARS-CoV-2. Compared to those with mild coronavirus disease 2019 (COVID-19) cases, individuals with severe disease exhibited elevated virus-neutralizing titers and antibodies against the nucleocapsid (N) and the receptor binding domain (RBD) of the spike protein…neutralizing and spike-specific antibody production persists for at least 5–7 months… nucleocapsid antibodies frequently become undetectable by 5–7 months.”
29) Anti-spike antibody response to natural SARS-CoV-2 infection in the general population, Wei, 2021“In the general population using representative data from 7,256 United Kingdom COVID-19 infection survey participants who had positive swab SARS-CoV-2 PCR tests from 26-April-2020 to 14-June-2021…we estimated antibody levels associated with protection against reinfection likely last 1.5-2 years on average, with levels associated with protection from severe infection present for several years. These estimates could inform planning for vaccination booster strategies.”
30) Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers, Lumley, 2021“12,541 health care workers participated and had anti-spike IgG measured; 11,364 were followed up after negative antibody results and 1265 after positive results, including 88 in whom seroconversion occurred during follow-up…a total of 223 anti-spike–seronegative health care workers had a positive PCR test (1.09 per 10,000 days at risk), 100 during screening while they were asymptomatic and 123 while symptomatic, whereas 2 anti-spike–seropositive health care workers had a positive PCR test… the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.”
31) Researchers find long-lived immunity to 1918 pandemic virus, CIDRAP, 2008
and the actual 2008 NATURE journal publication by Yu		“A study of the blood of older people who survived the 1918 influenza pandemic reveals that antibodies to the strain have lasted a lifetime and can perhaps be engineered to protect future generations against similar strains…the group collected blood samples from 32 pandemic survivors aged 91 to 101..the people recruited for the study were 2 to 12 years old in 1918 and many recalled sick family members in their households, which suggests they were directly exposed to the virus, the authors report. The group found that 100% of the subjects had serum-neutralizing activity against the 1918 virus and 94% showed serologic reactivity to the 1918 hemagglutinin. The investigators generated B lymphoblastic cell lines from the peripheral blood mononuclear cells of eight subjects. Transformed cells from the blood of 7 of the 8 donors yielded secreting antibodies that bound the 1918 hemagglutinin.” Yu: “here we show that of the 32 individuals tested that were born in or before 1915, each showed sero-reactivity with the 1918 virus, nearly 90 years after the pandemic. Seven of the eight donor samples tested had circulating B cells that secreted antibodies that bound the 1918 HA. We isolated B cells from subjects and generated five monoclonal antibodies that showed potent neutralizing activity against 1918 virus from three separate donors. These antibodies also cross-reacted with the genetically similar HA of a 1930 swine H1N1 influenza strain.”
32) Live virus neutralisation testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2, Gonzalez, 2021“No significant difference was observed between the 20B and 19A isolates for HCWs with mild COVID-19 and critical patients. However, a significant decrease in neutralisation ability was found for 20I/501Y.V1 in comparison with 19A isolate for critical patients and HCWs 6-months post infection. Concerning 20H/501Y.V2, all populations had a significant reduction in neutralising antibody titres in comparison with the 19A isolate. Interestingly, a significant difference in neutralisation capacity was observed for vaccinated HCWs between the two variants whereas it was not significant for the convalescent groups…the reduced neutralising response observed towards the 20H/501Y.V2 in comparison with the 19A and 20I/501Y.V1 isolates in fully immunized subjects with the BNT162b2 vaccine is a striking finding of the study.”
33) Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals, Camara, 2021“Characterized SARS-CoV-2 spike-specific humoral and cellular immunity in naïve and previously infected individuals during full BNT162b2 vaccination…results demonstrate that the second dose increases both the humoral and cellular immunity in naïve individuals. On the contrary, the second BNT162b2 vaccine dose results in a reduction of cellular immunity in COVID-19 recovered individuals.”
34) Op-Ed: Quit Ignoring Natural COVID Immunity, Klausner, 2021“Epidemiologists estimate over 160 million people worldwide have recovered from COVID-19. Those who have recovered have an astonishingly low frequency of repeat infection, disease, or death.”
35) Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection, Harvey, 2021“To evaluate evidence of SARS-CoV-2 infection based on diagnostic nucleic acid amplification test (NAAT) among patients with positive vs negative test results for antibodies in an observational descriptive cohort study of clinical laboratory and linked claims data…the cohort included 3 257 478 unique patients with an index antibody test…patients with positive antibody test results were initially more likely to have positive NAAT results, consistent with prolonged RNA shedding, but became markedly less likely to have positive NAAT results over time, suggesting that seropositivity is associated with protection from infection.”
36) SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study, Letizia, 2021“Investigated the risk of subsequent SARS-CoV-2 infection among young adults (CHARM marine study) seropositive for a previous infection…enrolled 3249 participants, of whom 3168 (98%) continued into the 2-week quarantine period. 3076 (95%) participants…Among 189 seropositive participants, 19 (10%) had at least one positive PCR test for SARS-CoV-2 during the 6-week follow-up (1·1 cases per person-year). In contrast, 1079 (48%) of 2247 seronegative participants tested positive (6·2 cases per person-year). The incidence rate ratio was 0·18 (95% CI 0·11–0·28; p<0·001)…infected seropositive participants had viral loads that were about 10-times lower than those of infected seronegative participants (ORF1ab gene cycle threshold difference 3·95 [95% CI 1·23–6·67]; p=0·004).” 
37) Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar, Bertollini, 2021“Of 9,180 individuals with no record of vaccination but with a record of prior infection at least 90 days before the PCR test (group 3), 7694 could be matched to individuals with no record of vaccination or prior infection (group 2), among whom PCR positivity was 1.01% (95% CI, 0.80%-1.26%) and 3.81% (95% CI, 3.39%-4.26%), respectively. The relative risk for PCR positivity was 0.22 (95% CI, 0.17-0.28) for vaccinated individuals and 0.26 (95% CI, 0.21-0.34) for individuals with prior infection compared with no record of vaccination or prior infection.”
38) Natural immunity against COVID-19 significantly reduces the risk of reinfection: findings from a cohort of sero-survey participants, Mishra, 2021“Followed up with a subsample of our previous sero-survey participants to assess whether natural immunity against SARS-CoV-2 was associated with a reduced risk of re-infection (India)… out of the 2238 participants, 1170 were sero-positive and 1068 were sero-negative for antibody against COVID-19. Our survey found that only 3 individuals in the sero-positive group got infected with COVID-19 whereas 127 individuals reported contracting the infection the sero-negative group…from the 3 sero-positives re-infected with COVID-19, one had hospitalization, but did not require oxygen support or critical care…development of antibody following natural infection not only protects against re-infection by the virus to a great extent, but also safeguards against progression to severe COVID-19 disease.”
39) Lasting immunity found after recovery from COVID-19, NIH, 2021“The researchers found durable immune responses in the majority of people studied. Antibodies against the spike protein of SARS-CoV-2, which the virus uses to get inside cells, were found in 98% of participants one month after symptom onset. As seen in previous studies, the number of antibodies ranged widely between individuals. But, promisingly, their levels remained fairly stable over time, declining only modestly at 6 to 8 months after infection… virus-specific B cells increased over time. People had more memory B cells six months after symptom onset than at one month afterwards… levels of T cells for the virus also remained high after infection. Six months after symptom onset, 92% of participants had CD4+ T cells that recognized the virus… 95% of the people had at least 3 out of 5 immune-system components that could recognize SARS-CoV-2 up to 8 months after infection.”  
40) SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe Islands, Petersen, 2021“The seropositive rate in the convalescent individuals was above 95% at all sampling time points for both assays and remained stable over time; that is, almost all convalescent individuals developed antibodies… results show that SARS-CoV-2 antibodies persisted at least 12 months after symptom onset and maybe even longer, indicating that COVID-19-convalescent individuals may be protected from reinfection.”
41) SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells, Jung, 2021“ex vivo assays to evaluate SARS-CoV-2-specific CD4+ and CD8+ T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe sustained polyfunctionality and proliferation capacity of SARS-CoV-2-specific T cells. Among SARS-CoV-2-specific CD4+ and CD8+ T cells detected by activation-induced markers, the proportion of stem cell-like memory T (TSCM) cells is increased, peaking at approximately 120 DPSO.”
42) Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection, Ansari, 2021“Analyzed 42 unexposed healthy donors and 28 mild COVID-19 subjects up to 5 months from the recovery for SARS-CoV-2 specific immunological memory. Using HLA class II predicted peptide megapools, we identified SARS-CoV-2 cross-reactive CD4+ T cells in around 66% of the unexposed individuals. Moreover, we found detectable immune memory in mild COVID-19 patients several months after recovery in the crucial arms of protective adaptive immunity; CD4+ T cells and B cells, with a minimal contribution from CD8+ T cells. Interestingly, the persistent immune memory in COVID-19 patients is predominantly targeted towards the Spike glycoprotein of the SARS-CoV-2. This study provides the evidence of both high magnitude pre-existing and persistent immune memory in Indian population.” 
43) COVID-19 natural immunity, WHO, 2021“Current evidence points to most individuals developing strong protective immune responses following natural infection with SARSCoV-2. Within 4 weeks following infection, 90-99% of individuals infected with the SARS-CoV-2 virus develop detectable neutralizing antibodies. The strength and duration of the immune responses to SARS-CoV-2 are not completely understood and currently available data suggests that it varies by age and the severity of symptoms. Available scientific data suggests that in most people immune responses remain robust and protective against reinfection for at least 6-8 months after infection (the longest follow up with strong scientific evidence is currently approximately 8 months).”
44) Antibody Evolution after SARS-CoV-2 mRNA Vaccination, Cho, 2021“We conclude that memory antibodies selected over time by natural infection have greater potency and breadth than antibodies elicited by vaccination…boosting vaccinated individuals with currently available mRNA vaccines would produce a quantitative increase in plasma neutralizing activity but not the qualitative advantage against variants obtained by vaccinating convalescent individuals.”
45) Humoral Immune Response to SARS-CoV-2 in Iceland, Gudbjartsson, 2020“Measured antibodies in serum samples from 30,576 persons in Iceland…of the 1797 persons who had recovered from SARS-CoV-2 infection, 1107 of the 1215 who were tested (91.1%) were seropositive…results indicate risk of death from infection was 0.3% and that antiviral antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis (para).”
46)  Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection, Dan, 2021“Analyzed multiple compartments of circulating immune memory to SARS-CoV-2 in 254 samples from 188 COVID-19 cases, including 43 samples at ≥ 6 months post-infection…IgG to the Spike protein was relatively stable over 6+ months. Spike-specific memory B cells were more abundant at 6 months than at 1 month post symptom onset.”
47) The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis of 12 011 447 individuals, Chivese, 2021“Fifty-four studies, from 18 countries, with a total of 12 011 447 individuals, followed up to 8 months after recovery, were included. At 6-8 months after recovery, the prevalence of detectable SARS-CoV-2 specific immunological memory remained high; IgG – 90.4%… pooled prevalence of reinfection was 0.2% (95%CI 0.0 – 0.7, I2 = 98.8, 9 studies). Individuals who recovered from COVID-19 had an 81% reduction in odds of a reinfection (OR 0.19, 95% CI 0.1 – 0.3, I2 = 90.5%, 5 studies).”
48) Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study, Sheehan, 2021“Retrospective cohort study of one multi-hospital health system included 150,325 patients tested for COVID-19 infection…prior infection in patients with COVID-19 was highly protective against reinfection and symptomatic disease. This protection increased over time, suggesting that viral shedding or ongoing immune response may persist beyond 90 days and may not represent true reinfection.” 
49) Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy, Vitale, 2020“The study results suggest that reinfections are rare events and patients who have recovered from COVID-19 have a lower risk of reinfection. Natural immunity to SARS-CoV-2 appears to confer a protective effect for at least a year, which is similar to the protection reported in recent vaccine studies.”
50) Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection, Hanrath, 2021“We observed no symptomatic reinfections in a cohort of healthcare workers…this apparent immunity to re-infection was maintained for at least 6 months…test positivity rates were 0% (0/128 [95% CI: 0–2.9]) in those with previous infection compared to 13.7% (290/2115 [95% CI: 12.3–15.2]) in those without (P<0.0001 χ2 test).” 
51) mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status, Neidleman, 2021“In infection-naïve individuals, the second dose boosted the quantity and altered the phenotypic properties of SARS-CoV-2-specific T cells, while in convalescents the second dose changed neither. Spike-specific T cells from convalescent vaccinees differed strikingly from those of infection-naïve vaccinees, with phenotypic features suggesting superior long-term persistence and ability to home to the respiratory tract including the nasopharynx.”
52) Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals, Grifoni, 2020“Using HLA class I and II predicted peptide “megapools,” circulating SARS-CoV-2-specific CD8+ and CD4+ T cells were identified in ∼70% and 100% of COVID-19 convalescent patients, respectively. CD4+ T cell responses to spike, the main target of most vaccine efforts, were robust and correlated with the magnitude of the anti-SARS-CoV-2 IgG and IgA titers. The M, spike, and N proteins each accounted for 11%–27% of the total CD4+ response, with additional responses commonly targeting nsp3, nsp4, ORF3a, and ORF8, among others. For CD8+ T cells, spike and M were recognized, with at least eight SARS-CoV-2 ORFs targeted.”
53) NIH Director’s Blog: Immune T Cells May Offer Lasting Protection Against COVID-19, Collins, 2021“Much of the study on the immune response to SARS-CoV-2, the novel coronavirus that causes COVID-19, has focused on the production of antibodies. But, in fact, immune cells known as memory T cells also play an important role in the ability of our immune systems to protect us against many viral infections, including—it now appears—COVID-19.An intriguing new study of these memory T cells suggests they might protect some people newly infected with SARS-CoV-2 by remembering past encounters with other human coronaviruses. This might potentially explain why some people seem to fend off the virus and may be less susceptible to becoming severely ill with COVID-19.”
54) Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants, Wang, 2021“Our study demonstrates that convalescent subjects previously infected with ancestral variant SARS-CoV-2 produce antibodies that cross-neutralize emerging VOCs with high potency…potent against 23 variants, including variants of concern.” 
55) Why COVID-19 Vaccines Should Not Be Required for All Americans, Makary, 2021“Requiring the vaccine in people who are already immune with natural immunity has no scientific support. While vaccinating those people may be beneficial – and it’s a reasonable hypothesis that vaccination may bolster the longevity of their immunity – to argue dogmatically that they must get vaccinated has zero clinical outcome data to back it. As a matter of fact, we have data to the contrary: A Cleveland Clinic study found that vaccinating people with natural immunity did not add to their level of protection.”
56) Protracted yet coordinated differentiation of long-lived SARS-CoV-2-specific CD8+ T cells during COVID-19 convalescence, Ma, 2021“Screened 21 well-characterized, longitudinally-sampled convalescent donors that recovered from mild COVID-19…following a typical case of mild COVID-19, SARS-CoV-2-specific CD8+ T cells not only persist but continuously differentiate in a coordinated fashion well into convalescence, into a state characteristic of long-lived, self-renewing memory.”
57) Decrease in Measles Virus-Specific CD4 T Cell Memory in Vaccinated Subjects, Naniche, 2004“Characterized the profiles of measles vaccine (MV) vaccine-induced antigen-specific T cells over time since vaccination. In a cross-sectional study of healthy subjects with a history of MV vaccination, we found that MV-specific CD4 and CD8 T cells could be detected up to 34 years after vaccination. The levels of MV-specific CD8 T cells and MV-specific IgG remained stable, whereas the level of MV-specific CD4 T cells decreased significantly in subjects who had been vaccinated >21 years earlier.” 
58) Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination, Palm, 2019“The success of vaccines is dependent on the generation and maintenance of immunological memory. The immune system can remember previously encountered pathogens, and memory B and T cells are critical in secondary responses to infection. Studies in mice have helped to understand how different memory B cell populations are generated following antigen exposure and how affinity for the antigen is determinant to B cell fate… upon re-exposure to an antigen the memory recall response will be faster, stronger, and more specific than a naïve response. Protective memory depends first on circulating antibodies secreted by LLPCs. When these are not sufficient for immediate pathogen neutralization and elimination, memory B cells are recalled.”
59) SARS-CoV-2 specific memory B-cells from individuals with diverse disease severities recognize SARS-CoV-2 variants of concern, Lyski, 2021“Examined the magnitude, breadth, and durability of SARS-CoV-2 specific antibodies in two distinct B-cell compartments: long-lived plasma cell-derived antibodies in the plasma, and peripheral memory B-cells along with their associated antibody profiles elicited after in vitro stimulation. We found that magnitude varied amongst individuals, but was the highest in hospitalized subjects. Variants of concern (VoC) -RBD-reactive antibodies were found in the plasma of 72% of samples in this investigation, and VoC-RBD-reactive memory B-cells were found in all but 1 subject at a single time-point. This finding, that VoC-RBD-reactive MBCs are present in the peripheral blood of all subjects including those that experienced asymptomatic or mild disease, provides a reason for optimism regarding the capacity of vaccination, prior infection, and/or both, to limit disease severity and transmission of variants of concern as they continue to arise and circulate.”
60) Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection, Wang, 2021“T-cell immunity is important for recovery from COVID-19 and provides heightened immunity for re-infection. However, little is known about the SARS-CoV-2-specific T-cell immunity in virus-exposed individuals…report virus-specific CD4+ and CD8+ T-cell memory in recovered COVID-19 patients and close contacts…close contacts are able to gain T-cell immunity against SARS-CoV-2 despite lacking a detectable infection.” 
61) CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants, Redd, 2021and Lee, 2021“The CD4 and CD8 responses generated after natural infection are equally robust, showing activity against multiple “epitopes” (little segments) of the spike protein of the virus. For instance, CD8 cells responds to 52 epitopes and CD4 cells respond to 57 epitopes across the spike protein, so that a few mutations in the variants cannot knock out such a robust and in-breadth T cell response…only 1 mutation found in Beta variant-spike overlapped with a previously identified epitope (1/52), suggesting that virtually all anti-SARS-CoV-2 CD8+ T-cell responses should recognize these newly described variants.”
62) Exposure to common cold coronaviruses can teach the immune system to recognize SARS-CoV-2,La Jolla, Crotty and Sette, 2020“Exposure to common cold coronaviruses can teach the immune system to recognize SARS-CoV-2”
63) Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans, Mateus, 2020“Found that the pre-existing reactivity against SARS-CoV-2 comes from memory T cells and that cross-reactive T cells can specifically recognize a SARS-CoV-2 epitope as well as the homologous epitope from a common cold coronavirus. These findings underline the importance of determining the impacts of pre-existing immune memory in COVID-19 disease severity.”
64) Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection, Dehgani-Mobaraki, 2021“Better understanding of antibody responses against SARS-CoV-2 after natural infection might provide valuable insights into the future implementation of vaccination policies. Longitudinal analysis of IgG antibody titers was carried out in 32 recovered COVID-19 patients based in the Umbria region of Italy for 14 months after Mild and Moderately-Severe infection…study findings are consistent with recent studies reporting antibody persistency suggesting that induced SARS-CoV-2 immunity through natural infection, might be very efficacious against re-infection (>90%) and could persist for more than six months. Our study followed up patients up to 14 months demonstrating the presence of anti-S-RBD IgG in 96.8% of recovered COVID-19 subjects.”
65) Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19, Juno, 2020“Characterized humoral and circulating follicular helper T cell (cTFH) immunity against spike in recovered patients with coronavirus disease 2019 (COVID-19). We found that S-specific antibodies, memory B cells and cTFH are consistently elicited after SARS-CoV-2 infection, demarking robust humoral immunity and positively associated with plasma neutralizing activity.” 
66) Convergent antibody responses to SARS-CoV-2 in convalescent individuals, Robbiani, 2020“149 COVID-19-convalescent individuals…antibody sequencing revealed the expansion of clones of RBD-specific memory B cells that expressed closely related antibodies in different individuals. Despite low plasma titres, antibodies to three distinct epitopes on the RBD neutralized the virus with half-maximal inhibitory concentrations (IC50 values) as low as 2 ng ml−1.” 
67) Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence, Hartley, 2020 “COVID-19 patients rapidly generate B cell memory to both the spike and nucleocapsid antigens following SARS-CoV-2 infection…RBD- and NCP-specific IgG and Bmem cells were detected in all 25 patients with a history of COVID-19.”
68) Had COVID? You’ll probably make antibodies for a lifetime, Callaway, 2021“People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades…the study provides evidence that immunity triggered by SARS-CoV-2 infection will be extraordinarily long-lasting.” 
69) A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2, Majdoubi, 2021In greater Vancouver Canada, “using a highly sensitive multiplex assay and positive/negative thresholds established in infants in whom maternal antibodies have waned, we determined that more than 90% of uninfected adults showed antibody reactivity against the spike protein, receptor-binding domain (RBD), N-terminal domain (NTD), or the nucleocapsid (N) protein from SARS-CoV-2.” 
70) SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19, Braun, 2020“The results indicate that spike-protein cross-reactive T cells are present, which were probably generated during previous encounters with endemic coronaviruses.” 
71) Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection, Wang, 2021“A cohort of 63 individuals who have recovered from COVID-19 assessed at 1.3, 6.2 and 12 months after SARS-CoV-2 infection…the data suggest that immunity in convalescent individuals will be very long lasting.”
72) One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms, Rank, 2021“Long-lasting immunological memory against SARS-CoV-2 after mild COVID-19.”
73) IDSA, 2021“Immune responses to SARS-CoV-2 following natural infection can persist for at least 11 months… natural infection (as determined by a prior positive antibody or PCR-test result) can confer protection against SARS-CoV-2 infection.”
74) Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study, Holm Hansen, 2021Denmark, “during the first surge (ie, before June, 2020), 533 381 people were tested, of whom 11 727 (2·20%) were PCR positive, and 525 339 were eligible for follow-up in the second surge, of whom 11 068 (2·11%) had tested positive during the first surge. Among eligible PCR-positive individuals from the first surge of the epidemic, 72 (0·65% [95% CI 0·51–0·82]) tested positive again during the second surge compared with 16 819 (3·27% [3·22–3·32]) of 514 271 who tested negative during the first surge (adjusted RR 0·195 [95% CI 0·155–0·246]).”

What can be concluded from the above evidence? That vaccinating our troops and police (and children), and in fact COVID recovered persons (and forcing/mandating vaccines), has no scientific or medical basis and can be extremely harmful and can even be deadly. The collective literature evidence we presented above unequivocally establishes (and is empirically undeniable) that protective immunity following natural infection with SARS-CoV-2 is durable and long lasting. 

This push therefore to separate society into two groups (vaccinated versus unvaccinated) is destructive and without any scientific basis. This push to mandate the vaccine and put those who chose not to vaccinate into unemployment is inexcusable. We must allow persons to make this personal decision to vaccinate or not based on their own values and preferences and needs. The science clearly shows that naturally acquired immunity is similar to or even superior to vaccine induced immunity by these non-sterilizing COVID-19 vaccines, and affords longer lasting and stronger protection against infection. Our military and police must be allowed to make the decisions independently, unafraid of any retribution or loss of income or privileges. The arguments why the military and police must be vaccinated (and forced and mandated) with these vaccines are nonsense and have no medical or scientific basis.